28-June-2023
English
Report on the WNT Workshop how to prepare the Test Guidelines Programme for emerging technologies | In December 2022, the OECD held a workshop to explore where and how to adapt the Test Guidelines to emerging technologies, and remain relevant and impactful. A number of projects and activities are emanating from this workshop discussions, including the revision of Guidance Document 34 on validation, and more to come.
27-June-2023
English
Initial Recommendations on Evaluation of Data from the Developmental Neurotoxicity (DNT) In-Vitro Testing Battery | This document includes the lessons learned from the application of this technology in the field of pharmaceuticals and considers a range of issues directly relevant to human exposure arising from the application of externally-applied dsRNA-based pesticides, and discusses possible effects of dsRNA exposure in mammals.
27-June-2023
English
Considerations for the Human Health Risk Assessment of Externally Applied ds-RNA-Based Pesticides | This report includes lessons learned from the application of this technology in the field of pharmaceuticals and considers a range of issues directly relevant to human exposure arising from the application of externally-applied dsRNA-based pesticides. It also discusses possible effects of dsRNA exposure in mammals.
5-juin-2023
Français
L'OCDE a mis en place le projet d’Enquêtes sur le consentement à payer pour éviter les effets négatifs sur la santé dus à l’exposition aux composés chimiques (SWACHE) afin d'établir des valeurs comparables du consentement à payer pour éviter les effets négatifs sur la santé dus à l'exposition aux produits chimiques suivants : asthme, l'infertilité, la perte de QI, les maladies rénales chroniques et le très faible poids à la naissance.
5-May-2023
English
Countries are taking action against toxic chemicals emitted into air, water and land by industry. How can countries track progress made towards this target? The new OECD report looks at Pollutant Release and Transfer Registers data as a means to track toxic releases to monitor chemical pollution in order to meet the United Nations Sustainable Development Goal Target 12.4.
27-April-2023
English
Children can be more vulnerable to environmental hazards posed by chemicals, due to their physiological differences and unique behaviour. This document presents the results of a survey conducted in 2021, aiming to identify currently available methodologies for assessing the risk of chemicals to children’s health and also identify possible needs for additional or missing parameters and for further guidance documents.
13-April-2023
English
This Guidance provides concise and practical information to help organisations identify the type of chemicals information shared on the eChemPortal - the Global Portal to Information on Chemical Substances and to define the best strategy to participate as a data source.
15-March-2023
English
These two documents compile information on activities related to the assessment of the safety of products derived from modern biotechnology, environmental safety (biosafety) and the safety of novel foods and feeds, at the international level between April 2021 and May 2022. The information was provided by OECD Members, partner countries and observer organisations participating in the work.
5-December-2022
English
This report presents current approaches used to derive biomonitoring values and provides globally harmonised recommendations on how-to derive and apply occupational biomonitoring assessment values. It is relevant for occupational health professionals and occupational safety and health specialists, regulatory authorities, industry, researchers, and stakeholders interested in addressing occupational and general population biomonitoring.
11-October-2022
English
GLP issues raised by testing labs are covered in this comprehensive list of questions and answers, recently updated with questions related to: Test Facility organisation and personnel, Quality Assurance, Equipment and computerized systems, Test items, reference items and samples/specimens (Biologicals, GMOs, etc.), SOPs, Management of the study, Histopathology, Archives and E-Archives and Monitoring Test Facility compliance by GLP CMAs.